Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11526 - 11550 of 12752 in total
Azelnidipine is a dihydropyridine calcium channel blocker. It is marketed by Daiichi-Sankyo pharmaceuticals, Inc. in Japan. It has a gradual onset of action and produces a long-lasting decrease in blood pressure, with only a small increase in heart rate, unlike some other calcium channel blockers . It is currently being...
Investigational
Matched Iupac: … 3-[1-(diphenylmethyl)azetidin-3-yl] 5-propan-2-yl 2-amino-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine …
Lecozotan has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Iupac: … 4-cyano-N-[(2R)-2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazin-1-yl]propyl]-N-(pyridin-2-yl)benzamide …
Cenerimod has been used in trials studying the treatment of Systemic Lupus Erythematosus.
Investigational
Matched Iupac: … (2S)-3-{4-[5-(2-cyclopentyl-6-methoxypyridin-4-yl)-1,2,4-oxadiazol-3-yl]-2-ethyl-6-methylphenoxy}propane …
CHF6001 has been used in trials studying the treatment of Asthma and Chronic Obstructive Pulmonary Disease.
Investigational
Matched Iupac: … 3,5-dichloro-4-[(2S)-2-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-[3-(cyclopropylmethoxy)-4 …
Experimental
Matched Iupac: … (1,3-dioxo-2,3,4,5,6,7-hexahydro-1H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane …
HIV Integrase Inhibitor is under investigation in clinical trial NCT00397566 (A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects).
Investigational
Matched Iupac: … 2-(1,1-dioxo-1lambda6,2-thiazinan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine …
Illicit
Withdrawn
Matched Iupac: … 2,2,2-trichloroethane-1,1-diol 2-(trimethylazaniumyl)acetate …
Experimental
Matched Iupac: … (1r,3r,5r,7r)-adamantan-2-one …
Experimental
Matched Iupac: … (2S)-2-amino-4-(hydroxycarbamoyl)butanoic acid …
Experimental
Matched Iupac: … (2S)-2-[(hydroxycarbamoyl)amino]-3-phenylpropanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-N-hydroxy-3-methylbutanamide …
Experimental
Matched Iupac: … (2S)-2-amino-6-(dimethylamino)hexanoic acid …
Experimental
Matched Iupac: … [hydroxy(propan-2-yl)carbamoyl]formic acid …
Experimental
Matched Iupac: … (2S)-2-amino-3-(sulfooxy)propanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-(phosphonosulfanyl)propanoic acid …
Experimental
Matched Iupac: … (2S,3R)-2-amino-3-hydroxybutanedioic acid …
Experimental
Matched Iupac: … (2R,3R)-2-amino-3-hydroxybutanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-6-(carboxyamino)hexanoic acid …
Experimental
Matched Iupac: … {[2-(4-iodophenyl)acetamido]methyl}phosphinic acid …
Experimental
Matched Iupac: … tert-butyl (2S)-2-amino-4-carbamoylbutanoate …
Experimental
Matched Iupac: … 4,5,6,7-tetrabromo-2-(methylsulfanyl)-1H-1,3-benzodiazole …
Chlorotoxin I-131 is investigated in clinical trials for treating brain cancer. Chlorotoxin I-131 binds to and reduces the activity of a matrix metalloproteinase (MMP) that regulates functioning of the chloride channels on cell membranes. Chlorotoxin is a small 36-amino-acid peptide that selectively binds to glioma cells but not normal brain...
Investigational
Matched Iupac: … {2-[4-(1,2-diphenylbutyl)phenoxy]ethyl}dimethylamine …
Experimental
Matched Iupac: … (2S)-2-[(ethoxycarbonyl)amino]-4-methylpentanoic acid …
Experimental
Matched Iupac: … [(1R)-1-amino-2-phenylethyl]boronic acid …
Nisoxetine is a selective norepinephrine reuptake inhibitor (SNRI) developed in the 1970s. It was originally investigated as an antidepressant but has no current clinical applications aside from being a research standard SNRI. It has been used to research obesity and energy balance, and exerts some local analgesia effects.
Experimental
Matched Iupac: … [3-(2-methoxyphenoxy)-3-phenylpropyl](methyl)amine …
Displaying drugs 11526 - 11550 of 12752 in total